Atlas Wealth LLC
- SEC CIK
- 0001964106
- Latest filing
- Jul 28, 2026
PVCT holding history
Provectus Biopharmaceuticals, Inc. in every 13F filed by Atlas Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PVCT overviewAll 13F holders of PVCTFull Q2 2026 holdings
- Shares (Q2 2026)
- 19,620
- Value
- $1.36K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 19,620 | $1.36K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 19,620 | $999 | <0.1% | +19,620 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −26,620−100.0% | Sold out | Holders |
| Q3 2025 | 26,620 | $2.37K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 26,620 | $1.92K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 26,620 | $2.66K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 26,620 | $3.20K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 26,620 | $2.61K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 26,620 | $3.39K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 26,620 | $4.87K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 26,620 | $2.25K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 26,620 | $2.25K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 26,620 | $3.06K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 26,620 | $4.39K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 26,620 | $2.88K | <0.1% | – | No prior filing | Holders |